Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imipenem”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Post-approval studies (Phase 4)UnknownNCT02616354
What this trial is testing

Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin

Who this might be right for
Sepsis
Southeast University, China 24
Large-scale testing (Phase 3)UnknownNCT05204368
What this trial is testing

Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40)

Who this might be right for
Complicated Urinary Tract Infection Including Acute Pyelonephritis
Evopoint Biosciences Inc. 780
Not applicableUnknownNCT04196608
What this trial is testing

In Vitro Activity of Ceftolozane/Tazobactam and Imipenem/Relebactam in Clinical Isolates of Pseudomonas Aeruginosa and Enterobacterales Collected From Hematology and Oncology Patients

Who this might be right for
Ceftolozane/TazobactamImipenem/RelebactamHematology and Oncology
Emilio Bouza 1,005
Large-scale testing (Phase 3)Study completedNCT00236834
What this trial is testing

The Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization

Who this might be right for
Nosocomial Pneumonia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 438
Large-scale testing (Phase 3)Study completedNCT03293485
What this trial is testing

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Who this might be right for
Complicated Intra-abdominal InfectionComplicated Urinary Tract Infection
Merck Sharp & Dohme LLC 83
Not applicableUnknownNCT02670239
What this trial is testing

Pharmacokinetics of Imipenem During Ex Vivo Lung Perfusion (EVLP)

Who this might be right for
Lung Transplantation
University of Turin, Italy 30
Testing effectiveness (Phase 2)Study completedNCT02321800
What this trial is testing

Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections

Who this might be right for
Urinary Tract Infections
Shionogi 452
Not applicableUnknownNCT01374256
What this trial is testing

Imipenem and Sulbactam in the Treatment of Imipenem-resistant Acinetobacter Baumannii Bacteremia

Who this might be right for
Acinetobacter Bacteraemia
Taipei Veterans General Hospital, Taiwan 200
Not applicableUnknownNCT03858387
What this trial is testing

PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients

Who this might be right for
Critical IllnessBacterial Infections
Prince of Songkla University 102
Large-scale testing (Phase 3)Study completedNCT05204563
What this trial is testing

Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)

Who this might be right for
Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
Evopoint Biosciences Inc. 450
Large-scale testing (Phase 3)Study completedNCT03583333
What this trial is testing

Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)

Who this might be right for
Hospital-Acquired Bacterial PneumoniaVentilator-Associated Bacterial Pneumonia
Merck Sharp & Dohme LLC 274
Testing effectiveness (Phase 2)Study completedNCT04983901
What this trial is testing

PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 100
Early research (Phase 1)Study completedNCT04147221
What this trial is testing

Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance

Who this might be right for
Sepsis
Hartford Hospital 9
Not applicableStudy completedNCT00443885
What this trial is testing

Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC

Who this might be right for
Gram Negative Organism
University of Pittsburgh 500
Large-scale testing (Phase 3)Study completedNCT02493764
What this trial is testing

Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)

Who this might be right for
Bacterial Pneumonia
Merck Sharp & Dohme LLC 537
Large-scale testing (Phase 3)Ended earlyNCT00589693
What this trial is testing

To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia

Who this might be right for
Ventilator-Associated Pneumonia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 274
Not applicableStudy completedNCT05048693
What this trial is testing

Use of New Antibiotics in Sweden

Who this might be right for
Multi-antibiotic Resistance
Uppsala University 41
Large-scale testing (Phase 3)Study completedNCT03969901
What this trial is testing

Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)

Who this might be right for
Suspected or Documented Gram-negative Bacterial Infection
Merck Sharp & Dohme LLC 115
Post-approval studies (Phase 4)UnknownNCT03776305
What this trial is testing

Imipenem in Critically Ill Patients

Who this might be right for
Critically Ill Patients With ECMO
Prince of Songkla University 12
Post-approval studies (Phase 4)Study completedNCT01721408
What this trial is testing

Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection

Who this might be right for
Intra-abdominal Infection
Pfizer 470
Next Page